A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

Stopped early · Phase 2

Conditions studied: Hematologic Diseases

In brief

This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.

Key facts

Study ID

NCT00208949

Run by

Emory University

People needed

50

Starts

2002-09-01

Expected to finish

2012-05-01

Last updated by the study team

2012-09-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All normal donors for patients undergoing allogeneic peripheral blood stem cell (PBSC) for hematologic diseases will be invited to participate in this research trial.
• All patients must meet criteria for transplantation.
• Final eligibility will be determined by the health professionals conducting this clinical trial.

You may not qualify if…

• Donors for patients undergoing selected or manipulated PBSC grafts are not eligible.
• Donors who are pregnant or lactating females and donors with a known hypersensitivity to either G-CSF or GM-CSF will be excluded from this study.
• Final eligibility will be determined by the health professionals conducting this clinical trial.

Where it is running

• Emory University Winship Cancer Institute — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.